Madhavbaug is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with the traditional Ayurveda practices. It uses non-invasive, multidisciplinary, and innovative therapies for treating chronic ailments. The company mainly offers treatment for (i) Health disease reversal, (ii) Diabetes Reversal, (iii) BP Management, (iv) Obesity management, Knee pain relief.
As of November 30, 2021, the company operates 274 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa, Karnataka, Delhi, and Chhattisgarh. Out of these 52 are company-owned and 222 are franchise clinics. The company also operates two cardiac prevention and rehabilitation hospitals in Khopoli and Nagpur respectively.
The company offers several wellness products through their online portal Madhavbaug Wellness, and has an online app called MIB Pulse App which helps heart patients.
Competitive Strengths:
The amalgamation of modern and ancient methods for curing diseases
Affordable and non-invasive treatments
Experienced leadership and well-trained team
In-house IT platform for operational efficiency and innovations
MIS system for better management
Company Financials:
| Particulars | For the year/period ended (₹ in Millions) | ||
|---|---|---|---|
| 30-Sep-21 | 31-Mar-21 | 31-Mar-20 | |
| Total Assets | 257.80 | 258.06 | 291.11 |
| Total Revenue | 315.65 | 522.79 | 752.97 |
| Profit After Tax | 13.54 | 15.47 | -5.57 |
Objects of the Issue:
- Funding Branding and Advertising expenses
- General corporate purpose
Madhavbaug IPO Details
| IPO Opening Date | Feb 10, 2022 |
| IPO Closing Date | Feb 15, 2022 |
| Issue Type | Fixed Price Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹73 per equity share |
| Market Lot | 1600 Shares |
| Min Order Quantity | 1600 Shares |
| Listing At | NSE SME |
| Issue Size | 2,771,200 Eq Shares of ₹10 (aggregating up to ₹20.23 Cr) |
| Fresh Issue | 2,771,200 Eq Shares of ₹10 (aggregating up to ₹20.23 Cr) |
Madhavbaug IPO Tentative Timetable
The Madhavbaug IPO open date is Feb 10, 2022, and the close date is Feb 15, 2022. The issue may list on Feb 23, 2022.
| IPO Open Date | Feb 10, 2022 |
| IPO Close Date | Feb 15, 2022 |
| Basis of Allotment Date | Feb 18, 2022 |
| Initiation of Refunds | Feb 21, 2022 |
| Credit of Shares to Demat Account | Feb 22, 2022 |
| IPO Listing Date | Feb 23, 2022 |
Madhavbaug IPO Lot Size
The Madhavbaug IPO market lot size is 1600 shares. A retail-individual investor can apply for up to 1 lots (1600 shares or ₹116,800).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 1600 | ₹116,800 |
| Maximum | 1 | 1600 | ₹116,800 |
Madhavbaug IPO Promoter Holding
| Pre Issue Share Holding | 90.08% |
| Post Issue Share Holding | 66.34% |
Madhavbaug IPO Review
VSAL has posted erratic financial performance so far. It is priced exorbitantly based on its latest performance with super-profits. It is going to spend nearly 80% of IPO proceeds on advertising and branding which raises concern. There is no harm in ignoring this IPO. Read detail review…
Madhavbaug IPO Subscription Status (Bidding Detail)
The Madhavbaug IPO is subscribed 0.60 times on Feb 11, 2022 12:40:00 PM. The public issue subscribed 0.77 times in the retail category, times in the QIB category, and 0.42 times in the NII category. Check Day by Day Subscription Details (Live Status)
Company Contact Information
Vaidya Sane Ayurved Laboratories Limited
Fl. 5, 1047, Shriram Bhawan,
Shukrawar Peth, Pune – 411002,
Maharashtra, India
Phone: +91 7738070019
Email: cs@madhavbaug.com
Website: https://madhavbaug.org/